NCT02663362 Development and Validation of Multi-nuclear Magnetic Resonance Imaging and Spectroscopy for Whole Body Human Applications
| NCT ID | NCT02663362 |
| Status | Recruiting |
| Phase | — |
| Sponsor | AdventHealth Translational Research Institute |
| Condition | Human Body Composition |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2012-02 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2012-02 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop and refine the techniques for using magnetic resonance imaging and magnetic resonance spectroscopy to understand the composition and function of the human body
Eligibility Criteria
Inclusion Criteria: * Male or female * Age 12 - 89 * Healthy (self assessed) * Weight under 350lbs * Able to walk 50 yards without stopping * Able to travel to hospital for study visits * Able to follow a 3-step command * Able to remain in Magnetic Resonance (MR) scanner for up to 2 hours Exclusion Criteria: * Have internal metal medical devices, including cardiac pacemakers, aortic or cerebral aneurysm clips, artificial heart valves, ferromagnetic implants, shrapnel, wire sutures, joint replacements, bone or joint pins/rods/screws, metal fragments in your eye, or non-removable jewelry such as rings. * Are unwilling or unable to complete the imaging procedures for the duration of the MRI scan due to claustrophobia or other reason. * Serious mental illness that might preclude subject's ability to comply with study treatment * Life expectancy of less than 1 year * Are pregnant or plan on becoming pregnant in the next 8 weeks.
Contact & Investigator
Heather Cornnell, PhD
PRINCIPAL INVESTIGATOR
Translational Research Institute for Metabolism and Diabetes
Frequently Asked Questions
Who can join the NCT02663362 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 89 Years, studying Human Body Composition. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02663362 currently recruiting?
Yes, NCT02663362 is actively recruiting participants. Contact the research team at tri@flhosp.org for enrollment information.
Where is the NCT02663362 trial being conducted?
This trial is being conducted at Orlando, United States.
Who is sponsoring the NCT02663362 clinical trial?
NCT02663362 is sponsored by AdventHealth Translational Research Institute. The principal investigator is Heather Cornnell, PhD at Translational Research Institute for Metabolism and Diabetes. The trial plans to enroll 250 participants.